Myriad Genetics Inc (NASDAQ:MYGN)

34.00
Delayed Data
As of Apr 27
 +0.41 / +1.22%
Today’s Change
31.56
Today|||52-Week Range
42.50
-0.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues182.9M188.8M168.8M184.4M
 
 
 
 
 
Cost of Goods Sold23.1M25.5M32.0M31.8M
 
 
 
 
 
Depreciation And Amortization3.5M5.5M6.0M6.0M
 
 
 
 
 
 
Operating ExpensesGross Income156.3M157.8M130.9M146.5M
 
 
 
 
 
General Expenses101.0M104.5M105.0M110.2M
 
 
 
 
 
Research And Development13.4M20.2M22.6M17.5M
 
 
 
 
 
Total Operating Expenses127.6M135.5M142.9M148.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income55.3M53.3M25.9M36.3M
 
 
 
 
 
Other Expenses-442.0K-908.0K-98.0K1.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income57.3M52.6M25.9M37.9M
 
 
 
 
 
Income Taxes-20.6M-18.9M-9.9M-13.9M
 
 
 
 
 
Net Income36.8M33.6M16.0M24.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS73.8M74.4M72.8M72.5M
 
 
 
 
 
Shares To Calculate EPS Diluted76.4M77.7M76.1M75.4M
 
 
 
 
 
 
Earnings Per ShareEPS$0.48$0.43$0.21$0.32
 
 
 
 
 
EPS Diluted$0.48$0.43$0.21$0.32
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account